Relx (RENX) Stock Price, News & Analysis

Company Overview

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands.

Key Stats

• Today's Range: $21.18 to $21.55
• 50-Day Range: N/A
• 52-Week Range: $20.06 to $23.30
• Volume: 547,934 shs
• Average Volume: 100,590 shs
• Market Capitalization: N/A
• P/E Ratio: 17.37
• Dividend Yield: 1.32%
• Price Target: N/A
• Consensus Rating: N/A

RENX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Relx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Relx investors own include Allena Pharmaceuticals (ALNA), Safeguard Scientifics (SFE), Gulfport Energy (GPOR), HighPoint Resources (HPR), Alto Ingredients (PEIX), Rigel Pharmaceuticals (RIGL) and Rosehill Resources (ROSE).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Computer and Technology
• Industry: Miscellaneous Publishing
• Sub-Industry: N/A
• Current Symbol: NYSE:RENX
• Previous Symbol: NYSE:ENL
• CUSIP: N/A
• CIK: 929872
• Web: www.relx.com
• Phone: 31-20-485-2222
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 17.37
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A